TRACERx 100: RNAseq data from the first 100 TRACERx tumours
TRACERx (TRAcking Cancer Evolution through therapy (Rx)) is a prospective cohort study designed to investigate intratumor heterogeneity (ITH) in relation to clinical outcome, and to determine the clonal nature of driver events and evolutionary processes in early stage non-small cell lung cancer (NSCLC). This study looks at the multi-region RNAseq data from the TRACERx100 cohort with high enough quality RNA available. There is RNAseq data from 164 regions (64 patients).
Type: Other
Archiver: European Genome-phenome Archive (EGA)
Cite
Click on a Dataset ID in the table below to learn more, and to find
out who to contact about access to these data
